Lanreotide diTFA

Lanreotide diTFA, a cutting-edge biomedicine of novel nature, is deployed in the intricate realm of acromegaly, an enigmatic hormonal disorder marked by the unwarranted surge in growth hormone secretion. Through virtue of embodying the essence of a somatostatin analog, this wonder drug efficaciously curbs the exocrine release of growth hormone, thus serving as a catalyst in abating the diverse array of notabilities accompanying acromegaly.

Online Inquiry

Specification Technical Data Related Products Featured Products Customer reviews and Q&A Useful Tools Publications

CAT#	R2026
CAS	1024499-83-9
M.F/Formula	C58H71F6N11O14S2
M.W/Mr.	1324.37

CAT#	Product Name	Inquiry
R1580	OV-1, sheep	Inquiry
R1315	Cyclo(RADfK)	Inquiry
R1426	Histatin 5	Inquiry
R1934	Deltibant	Inquiry
R1654	ReACp53	Inquiry

CAT#	Product Name	M.W	Molecular Formula	Inquiry
10-101-20	Goserelin Acetate	1269.43	C59H84N18O14	Inquiry
10-101-59	Liraglutide	3751.2	C172H265N43O51	Inquiry
R1574	Octreotide	1019.24	C₄₉H₆₆N₁₀O₁₀S₂	Inquiry
10-101-139	Myrcludex B			Inquiry
10-101-285	Teduglutide	3752.08	C164H252N44O55S	Inquiry
R1847	Sermaglutide	4114	C187H291N45O59	Inquiry
R1961	Carbetocin	988.2	C45H69N11O12S	Inquiry

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.